RENODAPT S 360MG TABLET

Renodapt S 360mg tablet is a potent immunosuppressant that contains Mycophenolate sodium as its active ingredient. Classified as an inosine monophosphate dehydrogenase (IMPDH) inhibitor, this medication plays a crucial role in preventing organ rejection in individuals who have undergone organ transplantation, such as kidney, heart, or liver surgery. It is typically prescribed as part of a comprehensive treatment plan that includes other immunosuppressive drugs to ensure the body accepts the new organ. Pregnant women should not take this medication due to the potential for congenital disabilities and miscarriage. If a woman becomes pregnant while taking this medication, she should stop taking it immediately. Women who are of childbearing age and taking this medication must use reliable contraception to avoid getting pregnant. Live vaccines should not be administered while taking this medication, as they may not work effectively, and there is a risk of infection. Individuals taking this drug should not donate blood during treatment or for at least six weeks after stopping treatment to ensure the medication has been eliminated from their system. Before taking this medicine, it is essential to inform your doctor if you have any pre-existing medical conditions, such as allergies, liver or heart disease. This drug may weaken your immune system, making you more susceptible to skin cancer. Therefore, minimizing your exposure to sunlight and UV radiation is crucial. Additionally, if you experience any unusual side effects after taking this medicine, such as bruising, fever, fatigue, dizziness, yellowing of the skin or eyes, vision problems, decreased urine production, or seizures, seek medical attention promptly. Renodapt S 360mg tablet is an immunosuppressive medication that may impact an infant’s developing immune system; therefore, it is not recommended for breastfeeding.